These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 15068908

  • 21. [Therapeutic efficacy of hematopoietic stem cell transplantation in patients with chronic myelogenous leukemia].
    Liu QF, Fan ZP, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1227-9, 1241. PubMed ID: 15567763
    [Abstract] [Full Text] [Related]

  • 22. Differences in proportion and dynamics of recipient hematopoiesis following hematopoietic cell transplantation in CML and IMF.
    Siebolts U, Thiele J, Zander T, Ditschkowski M, Beelen DW, Kröger N, Fehse B, Wickenhauser C.
    Oncol Rep; 2008 Jan; 19(1):287-92. PubMed ID: 18097609
    [Abstract] [Full Text] [Related]

  • 23. [HLA-identical sibling allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia in first chronic phase. Analysis of 51 cases].
    He Y, Feng SZ, Wang M, Wei JL, Qin TJ, Zhou Z, Zhai WJ, Qiu LG, Han MZ.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):389-92. PubMed ID: 16251016
    [Abstract] [Full Text] [Related]

  • 24. Marrow aplasia developing 13 years after HLA-identical sibling allogeneic transplantation for chronic myeloid leukaemia: successful treatment with antithymocyte globulin and peripheral blood stem cell infusion from the original donor.
    O'Donghaile D, Hayden PJ, McCarron SL, Doyle EM, Lawler M, Browne PV, Conneally E, Vandenberghe E, McCann SR.
    Eur J Haematol; 2006 Mar; 76(3):258-60. PubMed ID: 16451399
    [Abstract] [Full Text] [Related]

  • 25. KIR2DS5 is associated with leukemia free survival after HLA identical stem cell transplantation in chronic myeloid leukemia patients.
    van der Meer A, Schaap NP, Schattenberg AV, van Cranenbroek B, Tijssen HJ, Joosten I.
    Mol Immunol; 2008 Aug; 45(13):3631-8. PubMed ID: 18555529
    [Abstract] [Full Text] [Related]

  • 26. Inv (11)(p15q21) in donor-derived Ph-negative cells in a patient with chronic myeloid leukemia in relapse successfully treated with imatinib mesylate post allogeneic stem cell transplantation.
    Medeiros BC, Chun K, Kamel-Reid S, Lipton J.
    Am J Hematol; 2007 Aug; 82(8):758-60. PubMed ID: 17301975
    [Abstract] [Full Text] [Related]

  • 27. Validation of the EBMT risk score in chronic myeloid leukemia in Brazil and allogeneic transplant outcome.
    De Souza CA, Vigorito AC, Ruiz MA, Nucci M, Dulley FL, Funcke V, Tabak D, Azevedo AM, Byington R, Macedo MC, Saboya R, Penteado Aranha FJ, Oliveira GB, Zulli R, Martins Miranda EC, Azevedo WM, Lodi FM, Voltarelli JC, Simões BP, Colturato V, De Souza MP, Silla L, Bittencourt H, Piron-Ruiz L, Maiolino A, Gratwohl A, Pasquini R.
    Haematologica; 2005 Feb; 90(2):232-7. PubMed ID: 15710577
    [Abstract] [Full Text] [Related]

  • 28. Facilitated engraftment by intramedullary administered enriched allogeneic CD34+ cells?
    Yano M, Watanabe A, Kawano Y, Watanabe T, Takaue Y.
    Bone Marrow Transplant; 1999 Apr; 23(8):847-8. PubMed ID: 10231152
    [Abstract] [Full Text] [Related]

  • 29. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A, Kondo T, Yamamoto S, Sugita J, Onozawa M, Kahata K, Endo T, Shiratori S, Ota S, Obara M, Wakasa K, Takahata M, Takeda Y, Tanaka J, Hashino S, Nishio M, Koike T, Asaka M, Imamura M.
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [Abstract] [Full Text] [Related]

  • 30. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
    Kiehl MG, Kraut L, Schwerdtfeger R, Hertenstein B, Remberger M, Kroeger N, Stelljes M, Bornhaeuser M, Martin H, Scheid C, Ganser A, Zander AR, Kienast J, Ehninger G, Hoelzer D, Diehl V, Fauser AA, Ringden O.
    J Clin Oncol; 2004 Jul 15; 22(14):2816-25. PubMed ID: 15254049
    [Abstract] [Full Text] [Related]

  • 31. Persistence of various chromosomal aberrations in recipient cells during complete remission after bone marrow transplantation followed by graft rejection.
    Masuko M, Furukawa T, Yersser O, Narita M, Toba K, Koike T, Aizawa Y.
    Leuk Res; 2005 Sep 15; 29(9):1083-7. PubMed ID: 16038736
    [Abstract] [Full Text] [Related]

  • 32. [Recent progress in hematopoietic stem cell transplantation].
    Shinagawa K.
    Gan To Kagaku Ryoho; 2006 Jun 15; 33(6):727-35. PubMed ID: 16770089
    [Abstract] [Full Text] [Related]

  • 33. Cytogenetic evolution patterns in CML post-SCT.
    Karrman K, Sallerfors B, Lenhoff S, Fioretos T, Johansson B.
    Bone Marrow Transplant; 2007 Feb 15; 39(3):165-71. PubMed ID: 17211433
    [Abstract] [Full Text] [Related]

  • 34. Early allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era: a preliminary assessment.
    Simon W, Segel GB, Lichtman MA.
    Blood Cells Mol Dis; 2006 Feb 15; 37(2):116-24; discussion 125-7. PubMed ID: 16904348
    [Abstract] [Full Text] [Related]

  • 35. High CD4/CD8 ratio in allografts predicts adverse outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantation for chronic myeloid leukemia.
    Xu LP, Luo XH, Chang YJ, Liu DH, Liu KY, Chen YH, Huang XJ.
    Ann Hematol; 2009 Oct 15; 88(10):1015-24. PubMed ID: 19319533
    [Abstract] [Full Text] [Related]

  • 36. Resistant graft failure overcome with allogenic peripheral blood plus bone marrow stem cells.
    Arslan O, Seferoğlu A, Gürman G, Ilhan O, Koç H.
    Haematologia (Budap); 1998 Oct 15; 29(1):47-50. PubMed ID: 9704257
    [Abstract] [Full Text] [Related]

  • 37. Effect of allogeneic stem cell transplantation on bone marrow angiogenesis in chronic myelogenous leukemia.
    Kumar S, Litzow MR, Rajkumar SV.
    Bone Marrow Transplant; 2003 Dec 15; 32(11):1065-9. PubMed ID: 14625577
    [Abstract] [Full Text] [Related]

  • 38. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy.
    Yakoub-Agha I, Mesnil F, Kuentz M, Boiron JM, Ifrah N, Milpied N, Chehata S, Esperou H, Vernant JP, Michallet M, Buzyn A, Gratecos N, Cahn JY, Bourhis JH, Chir Z, Raffoux C, Socié G, Golmard JL, Jouet JP, French Society of Bone Marrow Transplantation and Cell Therapy.
    J Clin Oncol; 2006 Dec 20; 24(36):5695-702. PubMed ID: 17116940
    [Abstract] [Full Text] [Related]

  • 39. Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia.
    Kobbe G, Fenk R, Neumann F, Bernhardt A, Steidl U, Kondakci M, Graef T, Aivado M, Vaupel M, Huenerlituerkoglu AN, Kronenwett R, Pape H, Hildebrand B, Germing U, Haas R.
    Cytotherapy; 2004 Dec 20; 6(6):533-42. PubMed ID: 15764020
    [Abstract] [Full Text] [Related]

  • 40. Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Ataergin S, Arpaci F, Cetin T, Guran S, Yakicier C, Beyzadeoglu M, Ozet A.
    Am J Hematol; 2006 May 20; 81(5):370-3. PubMed ID: 16628734
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.